Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Remtec Search

The specialist European Medical Device and Life Science recruitment company, working internationally to assist candidates and clients from across the world. Remtec offers 2 main services: Executive search and Contingency selection focusing on sales, marketing and technical roles. Our extensive experience, combined with proven processes, allows us to offer an unprecedented service to employers seeking top quality candidates and to candidates seeking top quality employers.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Remtec Search
Remtec Search and Selection Ltd, Registered Office, Breaks House, Mill Court, Cambridge, CB22 5LD, United Kingdom
+44 (0)1223 550 860
Contact Remtec Search
Website

 Latest Content from PMHub 

Top 10 Tips for “Virtualizing” In-person Meetings

Videos and Podcasts | April 14, 2022 | Impetus Digital

While Pharma was already slowly pivoting towards virtual events as a substitute for, or supplement to, in-person meetings, COVID-19 quickly changed virtual events from a nice-to-have to a must. With...

Virtualizing Healthcare with Human-Centric Technology

Videos and Podcasts | April 14, 2022 | Impetus Digital

Dr. Patrick Carroll, Chief Medical Officer at Vida Health, discusses the importance of using a “whole health” approach to chronic disease management, how and why the human connection with a...

Onyx Health Joins Forces with Rare Disease Specialists Actigen

Press Releases | April 14, 2022 | Onyx Health

Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solutions.

From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting

Press Releases | April 14, 2022 | Nucleus Global

Nucleus Global’s Luis Perez shares his thoughts on this year’s meeting

Importance of Diversity in Pharma and Clinical Trials

White Papers and Resources | April 13, 2022 | Impetus Digital

No matter which sector you work in, diversity and inclusion are must-haves!

Launch excellence

Press Releases | April 12, 2022 | Lucid Group Communications Limited

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events

White Papers and Resources | April 11, 2022 | Impetus Digital

In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit internal event with 375 attendees....

Meet The Lucid Group Talent Team

Videos and Podcasts | April 11, 2022 | Lucid Group Communications Limited

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Celebrating the new UK rare diseases framework

White Papers and Resources | April 8, 2022 | Dice Medical Communications

Dice's take on the importance of the rare diseases framework

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Videos and Podcasts | April 8, 2022 | Impetus Digital

A version of this article was previously published on Pharmaphorum.There is not a single industry that has been left untouched by COVID-19. While the effects of the pandemic have been devastating...